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ABSTRACT: 
The hypocholesterolemic and atheroscleroprotective potentials of dietary 
consumption of hawthorn (dried fruit of Crataegus pinnatifida, Shan Zha) were 
investigated by monitoring plasma lipid profiles and aortic relaxation in 
Sprague-Dawley rats fed with either normal diet, high-cholesterol diet (HCD) or HCD 
supplemented with hawthorn powder (2%, w/w) (4 weeks). In HCD-fed rats, an 
increased plasma total cholesterol and LDL-cholesterol with a decreased 
HDL-cholesterol was observed, and consumption of hawthorn markedly suppressed 
the elevated total cholesterol and LDL-lipoprotein levels plus an increased 
HDL-cholesterol level. The blunted acetylcholine-induced, endothelium-dependent 
relaxation of isolated aortas of HCD-fed rats was improved by hawthorn. The 
development of fatty liver, an increased nitric oxide synthase activity and an elevated 
oxidative stress (as estimated by the attenuated levels of anti-oxidant enzymes) 
associated with HCD were attenuated by hawthorn. Thus, the results demonstrated 
that hawthorn consumption provides overall beneficial effects on reversing HCD 
associated detrimental changes. 
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1. Introduction 
 
Hypercholesterolemia is a major risk factor for the development and progression of 
atherosclerosis and related cardiovascular diseases (Prasad & Kalra, 1993; Deepa & 
Varalakshmi, 2005). A high-cholesterol diet (HCD) is a major environmental 
contributor to an unbalanced lipoprotein metabolism. It is associated with an 
increased prevalence of atherosclerosis which is the major source of morbidity and 
mortality in the developed world, and it claims more lives than all types of cancer 
combined (Stocker & Keaney, 2004). Previous reports have clearly indicated a 
positive correlation between serum cholesterol level and the risk of cardiovascular 
disease (Leys et al., 2002; Yu-Poth et al., 2004). Despite the fact that there are drugs 
available clinically for treating hypercholesterolemia, the consumption of functional 
foods/dietary supplements in lowering/controlling serum cholesterol levels and risk of 
cardiovascular diseases (Roberfroid, 1999) has gained enormous global acceptance 
over the years by the general public. 
Hawthorn (also known as Shan Zha which is the fruit of Crataegus species) is 
commonly used in Chinese dishes to reduce risk of cardiovascular diseases such as 
heart failure (Schwinger et al., 2000; Tauchert, 2002), arrhythmias (Makdessi, 1999) 
and hypertension (Walker et al., 2002). Apart from the fruit, Crataegus leaves have 
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been shown to possess beneficial effects on cardiovascular diseases. Crataegus leave 
with flower extract was shown to reduce the incidence of sudden cardiac death in 
certain patients (Holubarsch et al., 2008) and be effective in treating chronic heart 
failure (Pittler et al., 2008). Crataegus is a member of the Rosaceae family and there 
are more than 280 species worldwide (Upton, 1999), and Crataegus pinnatifida and 
Crataegus cuneata are the two common species cultivated and used in PR China 
(Zhang et al., 2001); whereas Crataegus monogyna and Crataegus laevigata are 
found in Europe (Wang et al, 1999). 
Consumption of hawthorn (Crataegus pinnatifida) altered the digestive enzymes 
of the stomach and cholesterol metabolism of the liver (Zhu, 1998), and a reduction in 
blood lipid and cholesterol levels has been reported (Shanthi et al., 1994). In addition, 
hawthorn contains abundant amount of antioxidants such as chlorogenic acid, 
epicatechin, hyperoside and quercetin (Liu et al., 2010) which may be useful in 
alleviating the adverse effects associated with low-density lipoprotein 
(LDL)-cholesterol oxidation in atherosclerosis (Schwinger et al., 2000; Stocker & 
Keaney, 2004). 
In this study, we tested the hypothesis that consumption of hawthorn provides an 
overall improvement/benefit to alleviate the detrimental outcomes associated with 
HCD of the liver and the cardiovascular systems. 
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2. Materials and methods 
 
2.1. Animals 
Male Sprague-Dawley rats (~550 g, 8 month-old) were supplied by the Department of 
Applied Biology and Chemical Technology, The Hong Kong Polytechnic University 
(Hong Kong SAR, PR China). Rats were housed under standard conditions 
(temperature 20 ± 1 °C, humidity 60 ± 10%, light from 6 a.m. to 6 p.m.) with free 
access to water. 21 rats were randomly divided into 3 groups (i.e. 7 rats per group): 
Control with normal rat chow, which was obtained from Guangdong Provincial 
Medical Laboratory Animal Center (Guangzhou, PR China) [composition: protein 
(~14%), fat (~10%) and carbohydrate (~76%)]. Hypercholesterolemia diet (HCD) 
contained normal rat chow with the supplement of cholic acid (1%), cholesterol (2%) 
and cooking oil (5.5%) as described elsewhere (Yan et al., 2006; Li et al., 2009). 
Hawthorn-treated group received HCD plus dried hawthorn powder (2%). The dried 
hawthorn herb was purchased from Hip Shing Hong Ltd. (Hong Kong SAR, China). 
After removal of the seeds, the dry fruit flesh was ground into powder (particles pass 
a sieve with a mesh size of 1 mm) using a coffee grinder. Rats were fed with different 
diets (as mentioned above) for 4 weeks before they were sacrificed for experiments. 
The voucher sample of hawthorn herb was stored in the laboratory of Dr. Peter H.F. 
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Yu (Department of Applied Biology and Chemical Technology, The Hong Kong 
Polytechnic University, Hong Kong). At the end of a 4-week treatment period, rats 
were fasted overnight, sacrificed by cervical dislocation and tissue samples (blood, 
livers and aortas) were collected for different experiments. The experimental protocol 
was conducted under the animal license issued by the Health Department of the 
Government of the Hong Kong SAR and the Animal Subjects Ethics Sub-committee 
(ASESC No. 05/21) of The Hong Kong Polytechnic University. All procedures were 
consistent with the Guide for the Care and Use of Laboratory Animals published by 
the US National Institutes of Health and the principles outlined in the Declaration of 
Helsinki. Every effort was made to limit animal suffering and to limit the number of 
animals used in this study. 
 
2.2. High performance liquid chromatography (HPLC) analysis on dried 
hawthorn sample 
Dried hawthorn fruit powder (10 g) was weighed and mixed with 100 ml of 80% 
ethanol and shaken in a horizontal shaker at 37 C, 300 rpm for 1 hr. After 1 hr, the 
solution was centrifuged at 2735 g for 3 min. The supernatant was collected and the 
residue was re-extracted for one more times with same volume of 80% ethanol. 
Finally, all of the supernatant was filtered using filter paper (Whatman no. 4). The 
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filtered solution was treated in the rotary evaporator (Laborota4000, Heidolph, 
Germany) to remove excess extraction solvent before lyophilizing in freeze dryer 
(Labconco, Freezone 6, MO, USA) for about 1 week. Dried extract (0.1 mg) was 
dissolved in 1 ml of 0.2% H3PO4 (pH= 2). The solution was diluted to 0.01 mg/ml and 
filtered by a 0.45µm filter before HPLC analysis. 
HPLC analyses were performed using an Agilent 1100 HPLC system (Milford, 
MA, USA) coupled to a photodiode array detector. The samples were separated on a 
reversed-phase C18 column (250 mm  4.6 mm i.d.) from Alltech Associate Inc. 
(Lokeren, Belgium) with a C18 guard column (7.5 mm × 4.6 mm i.d.) (Alltech, 
Lokeren, Belgium). The mobile phase consisted of acetonitrile (solvent A) and 0.2% 
H3PO4 pH= 2 (solvent B). At time = 0, the solvent A and B were in 1:9 (v/v) ratio. 
The gradient mobile phase was changed gradually to 89:11 (v/v) A to B ratio in 20 
min consisted of 24% acetonitrile and 76% acetic acid (5%). The eluent was 
monitored by a UV detector. The detection wavelength was set at 360 nm. An 
autosampler was utilized for sample injection with injection volume of 10 l.  
 
  8 
2.3. Chemicals 
Phenylephrine hydrochloride, heparin, indomethacin, acetylcholine hydrochloride 
(ACh), chlorogenic acid, quercetin, hyperoside and neostigmine bromide were 
obtained from Sigma Chemicals Co. (St. Louis, MO, USA). The kit for the 
determination of nitric oxide (NO) levels was provided by Nanjing Jiancheng 
Bioengineering Company (Nanjing, PR China). Other chemicals used were analytical 
grade. 
 
2.4. Analysis of blood lipoprotein-cholesterol levels 
Blood samples from the 12-h fasted rats were collected on day 28 of this study. The 
100 unit/ml heparin-containing blood was centrifuged at 1500 g for 15 min. Plasma 
was collected and stored at -20 C before analysis. Plasma concentrations of total 
cholesterol, triacylglycerol, HDL-cholesterol and LDL-cholesterol were analyzed and 
compared as per instructions of the manufacturer (Biosino Bio-technology and 
Science Inc., Beijing, PR China). 
 
2.5. Endothelium-dependent vasorelaxation of thoracic aortas 
The relaxation effects of isolated aorta were measured as described previously (Yan et 
al., 2006). Briefly, the thoracic aortas were harvested and the fat and the surrounding 
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connective tissues were carefully cleared under a dissecting microscope. The aortic 
rings (about 4 mm in length) were prepared and mounted between two stainless steel 
hooks in 5-ml, water-jacketed organ baths (37 C) containing Krebs’-Ringer 
bicarbonate solution (gassed with 95% O2/5% CO2 (pH = 7.4)) of the following 
composition (mM): NaCl, 118.0; KCl, 4.7; CaCl2, 2.5; MgSO4, 1.2; NaHCO3, 25.0; 
KH2PO4, 1.2 and glucose, 11.0. An optimal load of 15  1 mN was applied to the 
rings, and changes in tension were recorded by isometric force-displacement 
transducers connected to the PowerLab Data Acquisition system (AD Instruments, 
Sydney, NSW, Australia). Tissues were allowed to equilibrate for 60 min under the 
resting tension, and were washed with drug-free Krebs’-Ringer solution every 20 min, 
and the resting tension was readjusted, if necessary, before commencing the 
experiments. After equilibration, the aortic rings were sensitized with 40 mM KCl 
until two consecutive contractile responses were reproducible. To investigate the 
relaxant effects of acetylcholine, the preparations (in the presence of indomethacin (1 
M) and neostigmine (1 M)) were precontracted with phenylephrine (1 M, a 
concentration which elicits approximate 85% of maximum effective contraction (EC85) 
of the tissues). After a steady-state contraction was established, cumulative 
concentrations (1 nM - 100 M) of acetylcholine were added. Concentration-response 
curves were plotted as percentage relaxation of phenylephrine induced-contraction 
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versus the logarithmic concentration (in the organ bath) of acetylcholine added. 
 
2.6. Histological change of the livers 
At the end of the study, the whole liver was harvested from rats and rinsed in saline (3 
- 4 times) to remove as much blood as possible. The gross appearance of livers of 
individual rat was photographed for comparison. Sample of liver (~5 g) was dissected 
and immersed in formalin (10 %) until sectioning. Wax specimens of individual liver 
sample were prepared and stained using Hematoxylin and Eosin methods, as 
described previously (Ratcliffe, 1982). 
 
2.7. Determination of the antioxidant enzyme activities in the livers and kidneys 
To monitor the activities of antioxidant enzymes in both livers and kidneys, isolated 
liver (~1 g) and kidneys (~0.5 g) of each rat were weighted and kept at -80 C 
immediately until homogenization procedures. Each frozen sample was homogenized 
in ice-cold saline (1:1, w/v) using an ulteraturax T-25 homogenizer for 10 bursts of 10 
s each, separated by a pause of 15 s. Then, the homogenates were centrifuged at 150 
g for 5 min (4 C), and the supernatants were collected and stored at -20 C until 
enzyme activities analysis. Superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx) activities were measured using commercial kits 
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(Nanjing Jiancheng Bioengineering Institute, Nanjing, PR China). SOD, CAT and 
GPx activities are expressed as U/mg protein. The protein content was measured by 
Bradford method (Bio-Rad, Hercules, CA). 
 
 
2.8. Evaluation of NOS activities in the liver and kidneys 
The frozen samples were homogenized in ice-cold saline and the homogenates were 
centrifuged at 1500 g for 10 min (4 C). The supernatant was used for the 
determinations of NOS activity (expressed in U/mg protein). It was determined 
spectrophotometrically by measuring NO synthesis using the oxidation of 
oxyhaemoglobin to methaemoglobin by NO. The incubations contained 1.6 mM 
oxyhaemoglobin, 200 mM CaCl2, 1 mM MgCl2, 100 mM L-arginine, 100 mM 
NADPH, 50 mM L-valine (to inhibit arginase), 40 mM potassium phosphate pH 7.2 
and up to 20% v/v tissue supernatant. This method was described previously 
(Knowles et al., 1990). The protein content was measured by Bradford method 
(Bio-Rad, Hercules, CA, USA). 
 
2.9. Statistical analysis 
All data was expressed as means ± standard deviations (S.D.), and n denotes the 
  12 
number of replications for each data point. Relaxations (%) were expressed as the 
percentage of the phenylephrine (1 M)-induced contraction. GraphPad Prism 4.02 
(San Diego, California, USA) was used for curve fitting and the estimation of the 
magnitude of maximum relaxation (Rmanx). After validation of each parameter 
collected for homogeneity of variance, differences between groups were analyzed 
using one-way analysis of variance (SPSS, Version 15 for Windows; Chicago, IL, 
USA). Post hoc tests were performed for inter-group comparisons using the least 
significance difference test, and a P value of < 0.05 was considered significant.  
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3. Results 
 
3.1. HPLC analysis on dried hawthorn sample 
A representative HPLC chromatogram was shown in Figure 1. The 80% ethanol 
hawthorn extract (1 mg) was found to contain chlorogenic acid (0.81 ± 0.027 µg), 
hyperoside (0.43 ± 0.021 µg) and trace amount of quercetin. 
 
3.2. Plasma cholesterol and lipoprotein profiles 
The plasma lipid profiles: total cholesterol, triacylglycerols, HDL-cholesterol and 
LDL-cholesterol levels of various treatment groups of rats are summarized in Figure 1. 
An elevated total plasma cholesterol and LDL-cholesterol with a decreased 
HDL-cholesterol was observed in rats fed with high cholesterol diet (HCD) 
(HDL-cholesterol/LDL-cholesterol ratio: control, 3.41; HCD-fed, 0.67). 
Supplementation of the HCD with hawthorn powder (2%, w/w) markedly altered the 
lipid profiles: a suppression of total cholesterol (HCD-fed, 6.06 ± 0.19 mM; HCD + 
hawthorn-fed, 4.00 ± 0.48 mM) and LDL-lipoprotein levels with an increase in 
HDL-lipoprotein (Table 1) was recorded. There was an increase in serum 
HDL-lipoprotein/LDL-lipoprotein ratio (HCD-fed, 0.67; HCD + hawthorn-fed, 2.16). 
No apparent effect on triacylglycerol levels was observed in three groups of rats 
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(Table 1). 
The atherogenic index [(total serum cholesterol minus HDL) / HDL] (which 
estimates the relative risk of coronary heart disease) of HCD-fed rats was significantly 
higher (~ 100-fold) than controls (10.7 ± 2.56 versus 0.98 ± 0.24), and hawthorn 
supplement in HCD-fed rats restored the atherogenic index towards the control level 
(1.87 ± 0.46) (Table 1). 
 
3.3. Evaluation of relaxation responses 
After phenylephrine (1 M)-induced contraction reached the steady-state condition, 
acetylcholine (with 1 μM neostigmine, an anti-cholinesterase) was cumulatively 
added to the aortic preparations. Acetylcholine elicited a concentration-dependent (1 
nM - 100 M) aortic relaxation of the Normal, HCD-fed and HCD + SZ-fed rats with 
the maximum relaxation (Rmax) (100 M acetylcholine) of ~110, ~80 and ~90%, 
respectively (Fig. 3). In HCD-fed rat, the magnitude of acetylcholine-induced (0.3 to 
100 M) relaxation was attenuated compared to controls, and the blunted relaxation 
was restored, to a certain extent, in HCD + hawthorn-fed rats (Fig. 2). 
 
3.4. Histological examination of the liver 
The gross appearance of the liver from rats fed with Normal diet, HCD and HCD + 
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hawthorn is depicted in Fig. 3. The liver of control (Normal) rats has a relatively 
dark-red colour whereas the HCD-fed rats have an enlarged liver (Weight of liver in 
Normal diet-fed rats: 13.08  0.50 g; HCD-fed: 21.49  0.74 g; whereas HCD + 
hawthorn-fed: 17.15  0.36 g) with a yellowish colour. In rats fed with HCD + 
hawthorn, there was not as much enlargement of liver (with a relatively “lesser 
yellowish” colour) as that was observed in HCD-fed rat. Histological examination of 
the livers of both control rats and HCD + hawthorn-fed rats revealed an intact cell 
architecture (Figs. 3A and 3C). In contrast, the liver of HCD-fed rats illustrated poor 
cellularity with extensive lipid depositions and enlarged hepatocytes (Fig. 3B). In 
HCD + hawthorn-fed rats (Fig. 3C), a lesser degree of lipid deposition and 
hepatocytes enlargement was observed. 
 
3.5. Antioxidant enzyme activities in liver and kidney 
Table 2 depicts the activities of antioxidant enzymes: superoxide dismutase (SOD), 
catalase (CAT) and glutathione peroxidase (GPx) in the liver and kidneys of rats fed 
with either normal diet, HCD or HCD + hawthorn. The actvities of anti-oxidant 
enzymes (i.e. SOD, CAT and GPx) measured in the kidneys are generally lower than 
that measured in the liver (Table 2). In HCD-fed rats, a marked decrease of SOD 
activity (~47% decrease) was recorded, compared to control rats (Table 2). Hawthorn 
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supplement managed to prevent HCD-induced reduction of SOD activity of the liver 
(~13 % decrease) (Table 2). Similar to SOD activity, CAT activity of the liver was 
suppressed (~49% decrease) in HCD-fed rats (Fig. 5B), and the consumption of 
hawthorn restored, to a certain extent, the suppressed CAT activity (~12% decrease) 
(Figure 5B). Unlike SOD and CAT activities, neither HCD nor HCD + hawthorn 
treatments altered the GPx activity of the liver (Table 2). 
In contrast to the liver, only SOD (but not CAT and GPx) activity of the kidneys 
was suppressed in HCD-fed rats (but only a subtle suppression, ~16% decrease), and 
the supplement of hawthorn completely restored the reduced SOD caused by HCD 
(Table 2). 
 
3.6. Determination of NOS activities 
Comparing with the controls, the HCD-treated rats showed a marked increase of NOS 
activity in liver (110 % increase, P < 0.01 versus controls). No apparent change in 
NOS activity of the kidneys of all groups of rats was measured (Table 2). In animals 
fed with HCD + hawthorn, the elevated hepatic NOS activity caused by HCD was 
returned to the control/normal levels (Table 2). 
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4. Discussion 
 
It is well known that diet plays an important role in the control of cholesterol 
homeostasis. The consumption of cholesterol-enriched diet is regarded as an 
important factor in the development of cardiovascular diseases as it leads to the 
development of hyperlipidemia, atherosclerosis and abnormal lipid 
oxidation/metabolism (Onody, 2003). Thus, natural products with 
hypocholesterolemic and hypolipidemic properties may be useful in reducing the risk 
of cardiovascular disease development. In this study, we evaluated the effects of 
supplementation of hawthorn (dried fruit of Crataegus pinnatifida) on the 
lipoprotein-cholesterol profiles and vascular response of high cholesterol diet 
(HCD)-fed rats. It has been reported that fresh and dried hawthorn fruit flesh 
containing different amount of phenolic antioxidants (Liu et al., 2009). For mimicking 
the usage of hawthorn in China, dried hawthorn was used in the current study. It has 
been reported that rats fed with cholesterol enriched diet for 4 weeks showed 
significant increase in total cholesterol and LDL (Yan et al., 2006; Li et al., 2009), 
which lead to development of secondary complications e.g. fatty liver and 
hypertension as observed clinically. In addition, diet supplemented with 2% hawthorn 
was shown to have hypolipidemic effect in rabbits fed a high cholesterol diet (Zhang 
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et al., 2002b). Therefore, similar dose regime was adopted in the current study. 
Similar to previous clinical studies (Kannel et al., 1971; Yu-Poth et al., 1999; 
Jeppesen et al., 2006), in our study HCD consumption (4 weeks) resulted in an 
increased total cholesterol and LDL-cholesterol (so-called the “bad” 
cholesterol/lipoprotein) with a concomitant decreased HDL-cholesterol (the “good” 
lipoprotein-cholesterol). Despite all these detrimental/unfavorable changes of 
cholesterol/lipoprotein levels after HCD consumption, supplementation of hawthorn 
(4 weeks) with the HCD resulted in a marked decrease in total cholesterol and 
LDL-lipoprotein, and more importantly with an increase in HDL-lipoprotein. In line 
with these observations, histological examination revealed that HCD-fed rats have 
enlarged livers (with a yellowish colouration), accumulation of lipid deposition, loss 
of hepatocytes integrity and hepatocyes enlargement. These changes are probably 
associated with or responsible for the aberrant changes of cholesterol/lipoprotein 
observed (i.e. a fatty liver) in rats fed with HCD. 
In view of the overall anatomical changes of the liver after feeding with HCD, 
these biological changes may be considered, by rats (and even by humans), as a form 
of stress/inflammation (although we did not measure the inflammatory biomarkers, if 
any, present in blood). Thus, it is not surprising to observe an increase in the activity 
of NOS (presumably iNOS which participates in inflammation responses) of the liver 
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(but not kidneys) in HCD-fed rats, as described elsewhere (Kim et al., 2002). Perhaps, 
the inflammation associated with HCD is resulted from an attenuated level of hepatic 
antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx) as clearly illustrated in our study. Our results are in fact 
consistent with previous reports in which a high-fat diet induces critical oxidative 
damage in the liver (Prasamthi et al., 2005; Schrauwen, 2007). It is interesting to point 
out that the liver seems to be more vulnerable to HCD insults than the kidneys as only 
SOD but not CAT or GPx levels was attenuated. The underlying mechanisms 
responsible for the “differential effects” of HCD on the levels of antioxidant enzymes 
of the liver and the kidneys are unknown. Perhaps, it is related to the physiological 
functions of these organs i.e. metabolism (liver) versus excretion (kidneys). 
Nonetheless, our novel results demonstrate that consumption of hawthorn 
provided protective effects for the liver to overcome the detrimental biological effects 
associated with HCD. For instance, the suppressed levels of the hepatic SOD, CAT 
and GPx as well as SOD level in kidneys were normalized to levels as observed in 
rats fed with normal diet. In addition, there was a reduction of the elevated cholesterol 
(total) and LDL-cholesterol, an increased of HDL-cholesterol with a lesser degree of 
lipid deposition in the liver in rats fed with HCD plus hawthorn supplement. It is in 
agreement with previous findings in which hawthorn consumption prevented the 
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decrease of antioxidants levels like glutathione and -tocopherol and maintained the 
level of antioxidant enzyme activities in liver, aorta and heart of rats on atherogenic 
diet (Shanthi et al., 1994). Furthermore, the elevated NOS activity of the liver 
(HCD-fed rats) and the increased atherogenic index were reversed to the level as 
observed in the normal rats. It remains to be determined whether the 
hypocholesterolemic effects of hawthorn consumption is associated with either 
up-regulation of the hepatic LDL receptors (Rajendran et al., 1996; Zhang et al., 
2002a), reduction of the absorption of dietary cholesterol from intestine by 
down-regulation of intestinal acyl CoA: cholesterol acyltransferase activity (Zhang et 
al., 2002a) or alteration of the hepatic cholesterol metabolism (Zhang et al., 2002b). 
Taken together, our results suggest that hawthorn consumption carries 
atheroscleroprotection properties. 
Hypercholesterolemia and atherosclerosis have a close association with vascular 
dysfunction (Kuchan & Frango, 1994). In this study, our results clearly illustrated a 
blunted acetylcholine-induced vascular relaxation (an endothelium-dependent process) 
which represents an endothelial/nitric oxide dysfunction in HCD-fed rats which is 
consistent with reports previously described in humans (Sorensen et al., 1994) and 
animals (Matsumoto et al., 2004). Interestingly, hawthorn supplementation restored, 
only to a certain extent, the blunted acetylcholine-induced endothelium relaxation. It 
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is well known that components found in hawthorn such as quercetin, hyperoside and 
isoquercitrin possess relaxation effects through the endothelium-dependent cascade 
(Zhang et al., 2001; Taubert et al., 2002) and procyanidins (one of the agents found in 
hawthorn) has been suggested to be responsible for the endothelium-dependent 
NO-mediated relaxation in isolated rat aorta (Kim et al., 2000). 
Hawthorn (dried fruit of Crataegus pinnatifida) is commonly consumed in China; 
while Crataegus leaves with flowers are mainly use in Europe. The extracts of both 
parts showed beneficial effect on the cardiovascular system (Walker et al., 2002; 
Pittler et al., 2008). The similar pharmacological use of fruit and leave can be 
explained by the close chemical compositions for both parts of the herbs (Long et al., 
2006).  
In conclusion, our results suggest that consumption of hawthorn (2 % w/v., 4 
weeks) has significant hypocholesterolemic and vasoprotective activities in rats fed 
with hypercholesterolemic diet (4 weeks). In addition, hawthorn supplement seems to 
protect the liver in response to oxidative stress (probably via the elevation of 
anti-oxidant enzymes levels) as well as alleviate the magnitude of fatty liver 
development in response to HCD. In line with these observations, the elevated activity 
of NOS (presumably the inducible isoform of NOS (iNOS) which is up-regulated in 
response to stress/inflammation challenge) in the liver after HCD regiment was 
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normalized, as observed for the first time, by hawthorn consumption. In addition, the 
blunted NO/endothelium-mediated aortic relaxation (presumably related to the 
suppressed endothelial isoform of NOS (eNOS)-mediated effects) in rats fed with 
HCD was restored, only to a certain extent, after hawthorn consumption. Nonetheless, 
our novel results clearly illustrate that consumption of hawthorn powder provides an 
overall improvement of the hepatic and cardiovascular systems that may be important 
in treating hypercholesterolemia-related cardiovascular complications. 
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Figure legends 
 
Fig. 1 - Chromatogram of hawthorn sample used in this study.  
 
Fig. 2 - Cumulative concentration-response curves of acetylcholine constructed in the 
pre-constructed thoracic aorta of Normal, HCD and HCD + hawthorn groups.  
Data (a decrease in steady-state tension elicited by phenylephrine (1 M)) are 
expressed as means ± SEM, n = 4. *P < 0.05 compared to Control (Normal diet) 
group. 
 
Fig. 3 - Histological examination of the liver obtained from rats fed with Normal diet, 
HCD or HCD + hawthorn groups. Photographs of the cross-section (400 
magnification) of liver (top), and the gross appearance of the entire liver (bottom) are 
illustrated. 
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Table 1 - Serum lipid levels of rats fed with Normal diet (Control), HCD or HCD + 
hawthorn. 
Animals groups Control HCD HCD + hawthorn 
Total cholesterol (mmol/L) 2.21 ± 0.06 
6.06 ± 
0.19### 
4.00 ± 0.18###, *** 
Triacylglycerols (mmol/L) 0.71 ± 0.04 0.73 ± 0.04 0.72 ± 0.05 
LDL (mmol/L) 0.34 ± 0.04 
0.96 ± 
0.08### 
0.61 ± 0.03###, *** 
HDL (mmol/L) 1.16 ± 0.15 
0.66 ± 
0.11## 
1.32 ± 0.05*** 
Atherogenic index 0.98 ± 0.24 
10.70 ± 
2.56### 
1.87 ± 0.46*** 
Data are expressed as means ± S.D., n = 6 – 7.  
##p < 0.01 and ###p < 0.001 represent significant difference when compared with the 
Control group. 
***p < 0.001 represents significant difference when compared with the HCD group. 
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Table 2 - Enzyme activities in liver and kidney from rats fed with Normal diet 
(Control), HCD or HCD + hawthorn. 
Animals groups Control HCD HCD + hawthorn 
Liver    
SOD (U/mg) 
542.36 ± 
49.94 
286.38 ± 
54.06# 
471.96 ± 0.18* 
CAT (U/mg) 0.75 ± 0.07 
0.38 ± 
0.08## 
0.66 ± 0.10* 
GPx (U/mg) 
148.04 ± 
6.92 
154.64 ± 
12.82 
139.05 ± 8.44 
NOS (U/mg)  0.27 ± 0.09 
0.57 ± 
0.27## 
0.25 ± 0.13** 
Kidney    
SOD (U/mg) 
154.02 ± 
6.61 
129.00 ± 
5.65# 
156.69 ± 11.27* 
CAT (U/mg) 0.16 ± 0.02 0.15 ± 0.01 0.14 ± 0.01 
GPx (U/mg) 86 ± 4.76 72.98 ± 5.58 85.07 ± 6.25 
NOS (U/mg) 0.37 ± 0.08 0.37 ± 0.09 0.36 ± 0.11 
Data are expressed as means ± S.D., n = 6 – 7.  
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#p < 0.05 and ##p < 0.01 represent significant difference when compared with the 
Control group. 
*p < 0.05 and **p < 0.01 represent significant difference when compared with the 
HCD group. 
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